CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine Inc., today announced the launch of the research use and investigational use versions of FoundationOne®RNA, its broad tissue-based RNA test.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. today announced a partnership to integrate its comprehensive genomic profiling (CGP) and other testing services with Epic’s electronic ...

Foundation Medicine and Epic struck a deal to integrate comprehensive genomic profiling within Epic's electronic health records (EHRs), allowing for providers to order and review genomic profiling ...

LYNPARZA was approved based on positive results from the PROfound study for which Foundation Medicine served as the Next-Generation Sequencing (NGS) partner Prostate cancer is the second most common ...

Foundation Medicine this week announced a new partnership with Epic to integrate its genomic profiling and testing services into its electronic health system. Cambridge, Massachusetts-based Foundation ...

BOSTON, June 01, 2026--(BUSINESS WIRE)--Foundation Medicine, Inc., a global, patient-focused precision medicine company, and SWOG Clinical Trials Partnerships (SWOG CTP) today announced a strategic ...

The company's being acquired by long-time partner Roche Holdings. A stand-still provision that's kept Roche Holdings from acquiring or selling its Foundation Medicine shares expired earlier this year, ...

WS Development has scored the largest life science development in Boston since Vertex Pharmaceuticals' landmark Seaport deal in 2011. Cambridge-based Foundation Medicine has leased 580K SF of office ...

FoundationOne PGx includes genes associated with the metabolism of medicines that have strong clinical evidence and actionable guidelines, including DPYD Foundation Medicine, Inc., a global, ...

Foundation Medicine and Epic are partnering to enable clinicians to access genomic profiling and other testing services directly through their EHR system. Announced Thursday, the partnership aims to ...

One of Massachusetts' largest life science companies is in the market for new real estate, and a sublease may indicate its preferred neighborhood. The Cambridge-based company was also looking at ...

SWOG’s network of investigators at more than 1,300 sites across the United States can collaborate with Foundation Medicine on biomarker-driven research and clinical trials, as well as access the ...